✦ LIBER ✦

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401

✍ Scribed by Nogami, Naoyuki; Hotta, Katsuyuki; Kuyama, Shoichi; Kiura, Katsuyuki; Takigawa, Nagio; Chikamori, Kenichi; Shibayama, Takuo; Kishino, Daizo; Hosokawa, Shinobu; Tamaoki, Akihiko; Harita, Shingo; Tabata, Masahiro; Ueoka, Hiroshi; Shinkai, Tetsu; Tanimoto, Mitsune

Book ID: 119320546
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 220 KB
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2011.01.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacological study of a

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer

✍ Shibayama, Takuo; Hotta, Katsuyuki; Takigawa, Nagio; Tada, Atsuhiko; Ueoka, Hiro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II trial of amrubicin and carbopla

Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer

✍ Hirose, Takashi; Nakashima, Masanao; Shirai, Takao; Kusumoto, Sojiro; Sugiyama, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

A Phase II Study of Higher Dose Weekly T

A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer

✍ David R. Spigel; F. Anthony Greco; Howard A. Burris III; Dianna L. Shipley; Bobb 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 318 KB

Phase I and pharmacologic study of weekl

Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial

✍ Chiyoe Kitagawa; Hideo Saka; Shigehisa Kajikawa; Kouki Mori; Masahide Oki; Ryuji 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 301 KB

Randomised Phase II study of topotecan/c

Randomised Phase II study of topotecan/cisplatin versus topotecan/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Combination of topotecan and cisplatin i

Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)

✍ Christos Christodoulou; Haralambos P. Kalofonos; Evangelos Briasoulis; Dimitrios 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 201 KB